Found 6 matching trials
TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer PHASE2 Status - CLOSED TO PATIENT ENROLLMENT (CNPE)
The study is being conducted ...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1 This phase I/IIa trial studies the side effects and best dose of a type of ...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma PHASE1 This study is for patients that have a cancer called Multiple Myeloma, mono...
Show More Status
Active Not Recruiting
Location
Harris Health Ben Taub Hospital
Learn More & Join Trial
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL PHASE1 Patients have a type of lymph gland disease called Hodgkin or non-Hodgkin l...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). PHASE1 Investigators have previously used this sort of therapy to treat Hodgkin or...
Show More Location
Texas Children's Hospital
Learn More & Join Trial
TAA-Specific CTLS for Solid Tumors (TACTASOM) PHASE1 This is a clinical trial for patients with a solid tumor which has come bac...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial